Skip to Content
Find More Like This
Return to Search

Treatment of Cardiovascular Disorders Using the Cell Differentiation Signaling Protein Nell1

United States Patent Application

View the Complete Application at the US Patent & Trademark Office
Oak Ridge National Laboratory - Visit the Partnerships Directorate Website
It has been identified in accordance with the present invention that Nell1 is essential for normal cardiovascular development by promoting proper formation of the heart and blood vessels. The present invention therefore provides therapeutic methods for treating cardiovascular disorders by employing a Nell1 protein or nucleic acid molecule.
Culiat, Cymbeline T. (Oak Ridge, TN)
UT-Battelle, LLC (Oak Ridge TN)
14/ 242,073
April 1, 2014
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH [0002] This invention was made with Government support under Contract No. DE-ACO5-000R22725 between the United States Department of Energy and UT-Battelle, LLC. The Government has certain rights in this invention.